Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
How to apply: uom.link/pgr-apply-2425 This 3.5-year PhD project is fully funded for home students or EU students with settled status; the successful candidate will receive a tax-free stipend set at
-
are searching for a motivated PhD candidate to design practical over-the-air computing algorithms and protocols for future edge AI applications. About the employer The research of this PhD position will be
-
/research-groups/CRITIX/ ) headed by Prof. Marcus Völp. The team focuses on critical information infrastructures and cyber-physical systems with the aim to protect our most sensitive and valuable assets. We
-
, dynamical systems and statistical physics. The candidate will be jointly supervised by the Coventry team Dr Fei He and the Stellenbosch team Prof. Francesco Petruccione . This project will contribute
-
Description At the Faculty of Chemistry and Food Chemistry, the Chair of Theoretical Chemistry offers a position as Research Associate / PhD Student (m/f/x) (subject to personal qualification
-
, which will consist of the PhD researcher, a PostDoc researcher (R programmer, consultant), undergraduate students, and Prof. Jakub Hofman. 4-year Ph.D. programme with financial support for 4 years
-
Doctoral Programs – 41th cycle – Academic year 2025/2026 APPLICATION DEADLINE: 27 AUGUST 2025 The Scuola Superiore Meridionale (SSM) hereby announces a call for applications for 50 PhD scholarships
-
. The project will involve significant collaboration, sample exchange, semiconductor and device characterisation. For more information on the position please contact Prof. Phil Dale phillip.dale@uni.lu or Prof
-
Researcher (R1) Positions PhD Positions Country Germany Application Deadline 30 Sep 2025 - 23:59 (Europe/Berlin) Type of Contract Temporary Job Status Part-time Offer Starting Date 1 Dec 2025 Is the job funded
-
suggest hypotheses for therapeutic targeting. This PhD studentship is part of the LifeArc ARDT, a UK-wide £12m partnership between Newcastle, Birmingham, and Belfast to accelerate rare disease trials